Treatment facility volume and survival in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Geynisman, Daniel M. [1 ]
Handorf, Elizabeth [1 ]
Zibelman, Matthew R. [1 ]
Plimack, Elizabeth R. [1 ]
Uzzo, Robert [1 ]
Kutikov, Alexander [1 ]
Smaldone, Marc C. [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
594
引用
收藏
页数：1
相关论文
共 50 条
  • [1] THE IMPACT OF FACILITY TYPE AND VOLUME ON SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Elshabrawy, Ahmed
    Wang, Hanzhang
    Oelsen, James
    Liss, Michael
    Kaushik, Dharam
    Pruthi, Deepak
    Ramamurthy, Chethan
    Mansour, Ahmed M.
    JOURNAL OF UROLOGY, 2020, 203 : E916 - E917
  • [2] Impact of facility type and volume on survival in patients with metastatic renal cell carcinoma
    Dursun, Furkan
    Elshabrawy, Ahmed
    Wang, Hanzhang
    Oelsen, James
    Liss, Michael
    Kaushik, Dharam
    Ramamurthy, Chethan
    Rodriguez, Ronald
    Mansour, Ahmed M.
    CANADIAN JOURNAL OF UROLOGY, 2021, 28 (05) : 10806 - 10816
  • [3] Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis
    Joshi, Shreyas S.
    Handorf, Elizabeth A.
    Zibelman, Matthew
    Plimack, Elizabeth R.
    Uzzo, Robert G.
    Kutikov, Alexander
    Smaldone, Marc C.
    Geynisman, Daniel M.
    EUROPEAN UROLOGY, 2018, 74 (03) : 387 - 393
  • [4] Treatment compliance in patients with metastatic renal cell carcinoma.
    Chen, C.
    Hess, G. P.
    Hill, J. W.
    Liu, Z.
    Agarwala, S. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Impact of statins and survival outcomes in patients with metastatic renal cell carcinoma.
    McKay, Rana R.
    Lin, Xun
    Albiges, Laurence K.
    Fay, Andre Poisl
    Kaymakcalan, Marina Dusevic
    Mickey, Suzanne S.
    Ghoroghchian, Paiman Peter
    Bhatt, Rupal Satish
    Simantov, Ronit
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [6] Nephrectomy status, race, and overall survival in patients with metastatic renal cell carcinoma.
    Robertson, Dale Kesley
    Zhang, Chao
    Liu, Yuan
    Gillespie, Theresa Wicklin
    Kucuk, Omer
    Carthon, Bradley Curtis
    Master, Viraj A.
    Issa, Muta
    Petros, John
    Harris, Wayne B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] New treatment approaches for metastatic renal cell carcinoma.
    Nanus D.M.
    Current Oncology Reports, 2000, 2 (5) : 417 - 422
  • [8] The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era
    Chen, Yu-Wei
    Ornstein, Moshe C.
    Wood, Laura S.
    Allman, Kimberly D.
    Martin, Allison
    Beach, Jennifer
    Gilligan, Timothy
    Garcia, Jorge A.
    Rini, Brian I.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (10) : 470.e19 - 470.e29
  • [9] The impact of facility case volume on overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
    Chen, Yu-Wei
    Tullio, Katherine
    Ornstein, Moshe Chaim
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Survival trends of men and women with metastatic clear cell renal cell carcinoma.
    Grigg, Claud
    Trufan, Sally
    Clark, Peter E.
    Riggs, Stephen Boyd
    Zhu, Jason
    Matulay, Justin T.
    Raghavan, Derek
    Burgess, Earle F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345